This paper evaluates trustworthiness criteria for public health agencies, highlighting scientific competence and institutional design.
How should we evaluate the trustworthiness of public health agencies (PHAs) such as the Centers for Disease Control and Prevention (CDC) and the Food and Drugs Administration (FDA)? This paper shall answer this question by arguing that PHAs testify as a collective and that conditions of trustworthiness must be evaluated at the collective level. The evaluative criteria consist of scientific competence, justified moral and political considerations and proper institutional design.
No takes yet. Share an insight, caveat, or question.
George Kwasi Barimah (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: